Written question asked by Jason McCartney (Conservative) on Tuesday, 17 March 2015, in the House of Commons. It was due for an answer on Thursday, 19 March 2015. It was answered by Jane Ellison (Conservative) on Tuesday, 24 March 2015 on behalf of the Department of Health.
Meningitis: Vaccination
- Question
-
To ask the Secretary of State for Health, pursuant to the Answer of 11 March 2015 to Question 226346, when he expects negotiations with GlaxoSmithKline on the meningitis B vaccine to be concluded.
- Answer
-
We are seeking to reach a positive conclusion to the negotiations with GlaxoSmithKline for supply of the meningococcal B (MenB) vaccine, Bexsero® at a cost-effective price, as recommended by the Joint Committee on Vaccination and Immunisation, as soon as possible.
The Department has had a number of meetings with the manufacturer and is continuing to meet.
Secondary information
- Type
- Written question
- Reference
- 227877
- Session
- 2014-15
- Related items
- Grouped for answer
- Yes
- Subjects
- Vaccination Meningitis GlaxoSmithKline
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2022-11-28 15:16:19 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2014-15/227877
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2014-15/227877
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2014-15/227877